The Impact of LY487379 or CDPPB on eNOS Expression in the Mouse Brain and the Effect of Joint Administration of Compounds with NO• Releasers on MK-801- or Scopolamine-Driven Cognitive Dysfunction in Mice

Agata Płoska,Anna Siekierzycka,Paulina Cieślik,Lawrence W. Dobrucki,Leszek Kalinowski,Joanna M. Wierońska

DOI: https://doi.org/10.3390/molecules29030627

IF: 4.6

2024-01-30

Molecules

Abstract:The role of endothelial nitric oxide synthase (eNOS) in the regulation of a variety of biological processes is well established, and its dysfunction contributes to brain pathologies, including schizophrenia or Alzheimer's disease (AD). Positive allosteric modulators (PAMs) of metabotropic glutamate (mGlu) receptors were shown to be effective procognitive compounds, but little is known about their impact on eNOS expression and stability. Here, we investigated the influence of the acute and chronic administration of LY487379 or CDPPB (mGlu2 and mGlu5 PAMs), on eNOS expression in the mouse brain and the effect of the joint administration of the ligands with nitric oxide (NO) releasers, spermineNONOate or DETANONOate, in different combinations of doses, on MK-801- or scopolamine-induced amnesia in the novel object recognition (NOR) test. Our results indicate that both compounds provoked eNOS monomer formation, and CDPPB at a dose of 5 mg/kg exaggerated the effect of MK-801 or scopolamine. The coadministration of spermineNONOate or DETANONOate enhanced the antiamnesic effect of CDPPB or LY487379. The best activity was observed for ineffective or moderate dose combinations. The results indicate that treatment with mGluR2 and mGluR5 PAMs may be burdened with the risk of promoting eNOS uncoupling through the induction of dimer dissociation. Administration of the lowest possible doses of the compounds with NO• donors, which themselves have procognitive efficacy, may be proposed for the treatment of schizophrenia or AD.

chemistry, multidisciplinary,biochemistry & molecular biology

What problem does this paper attempt to address?

The paper aims to explore the effects of two metabotropic glutamate receptor (mGlu) positive allosteric modulators (PAMs), LY487379 (mGlu2 PAM) and CDPPB (mGlu5 PAM), on the expression of endothelial nitric oxide synthase (eNOS) in the mouse brain, as well as the impact of these compounds when used in combination with nitric oxide (NO) donors on cognitive dysfunction in mice. Specifically, the study focuses on the following points: 1. **Effects on eNOS expression**: The study investigated the effects of acute and chronic administration of LY487379 and CDPPB on the dimer/monomer ratio (D/M ratio) and monomer/total protein ratio (M/T ratio) of eNOS in the mouse brain. 2. **Therapeutic effects on cognitive dysfunction**: The study examined the therapeutic effects of LY487379 and CDPPB in combination with NO donors (such as spermine NONOate and DETA NONOate) on MK-801 or scopolamine-induced cognitive dysfunction. The main objective of the research is to evaluate whether these compounds can improve cognitive dysfunction induced by MK-801 or scopolamine and to explore their potential mechanisms, particularly in relation to eNOS expression. Additionally, the study investigates the effects of different dose combinations to find the most effective treatment regimen.

The Impact of LY487379 or CDPPB on eNOS Expression in the Mouse Brain and the Effect of Joint Administration of Compounds with NO• Releasers on MK-801- or Scopolamine-Driven Cognitive Dysfunction in Mice

Nitric Oxide-Dependent Mechanisms Underlying MK-801- or Scopolamine-Induced Memory Dysfunction in Animals: Mechanistic Studies

A Comparative Study of the Impact of NO-Related Agents on MK-801- or Scopolamine-Induced Cognitive Impairments in the Morris Water Maze

Psychotomimetic Effects of Different Doses of MK-801 and the Underlying Mechanisms in a Selective Memory Impairment Model

Procognitive activity of nitric oxide inhibitors and donors in animal models

Bidirectional Variation in Glutamate Efflux in the Medial Prefrontal Cortex Induced by Selective Positive and Negative Allosteric Mglur5 Modulators

The Mglu5 Positive Allosteric Modulator LSN2463359 Differentially Modulates Motor, Instrumental and Cognitive Effects of NMDA Receptor Antagonists in the Rat

Depletion of Microglia with PLX3397 Attenuates MK-801-induced Hyperactivity Associated with Regulating Inflammation-Related Genes in the Brain

NMDA Receptor Hypofunction Induces Dysfunctions of Energy Metabolism and Semaphorin Signaling in Rats: a Synaptic Proteome Study.

mGluR5 Positive Allosteric Modulation Prevents MK-801 Induced Increases in Extracellular Glutamate in the Rat Medial Prefrontal Cortex

Impact of Two Neuronal Sigma-1 Receptor Modulators, PRE084 and DMT, on Neurogenesis and Neuroinflammation in an Aβ1-42-Injected, Wild-Type Mouse Model of AD

Propane-2-sulfonic acid octadec-9-enyl-amide alleviates scopolamine-induced spatial learning and memory deficits in mice

Synergistic Behavioral and Neuroplastic Effects of Psilocybin-NMDAR Modulator Administration.

Neurophysiological signals as potential translatable biomarkers for modulation of metabotropic glutamate 5 receptors

Selective Enhancement of the Interneuron Network and Gamma-Band Power via GluN2C/GluN2D NMDA Receptor Potentiation

Europinidin Attenuates Methamphetamine-induced Learning and Memory Impairments and Hippocampal Alterations in Rodents: Based on Molecular Docking through a Mechanism of Neuromodulatory Cytokines/ Caspases-3/ CREB/BDNF Pathway

Assessment of the Target Engagement and d-Serine Biomarker Profiles of the d-Amino Acid Oxidase Inhibitors Sodium Benzoate and PGM030756

Poliumoside inhibits apoptosis, oxidative stress and neuro-inflammation to prevent intracerebroventricular Streptozotocin-induced cognitive dysfunction in Sprague-Dawley Rats: in in-vivo, in-vitro and in-silico study.

In Silico Studies with In Vivo Analysis and Post Mortem ADME-Tox Profiling in Mice

An In Vitro and In Vivo Investigation

Modulating NMDA receptors to treat MK-801-induced schizophrenic cognition deficit: effects of clozapine combining with PQQ treatment and possible mechanisms of action